D-0751-2026 Class II Ongoing
FDA drug recall D-0751-2026 was initiated by Apollo Care, LLC on July 29, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material The recall status is ongoing. Affected quantity: 24,608 vials..
Recall Details
- Product Type
- Drugs
- Report Date
- August 19, 2026
- Initiation Date
- July 29, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,608 vials.
Product Description
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02
Reason for Recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Distribution Pattern
Nationwide within the U.S
Code Information
Lot: AC-017125, Exp. 8/30/2026; AC-017138, AC-017147, AC-017214, AC-017226, AC-017228, Exp. 12/31/2026.